Mary Lynne Hedley
Equibles does not estimate personal net worth.
About Mary Lynne Hedley
Earlier roles on record: Board Member at Centessa Pharmaceuticals plc (CNTA) until June 24, 2026. Centessa Pharmaceuticals plc reported in an 8-K filed June 24, 2026 that Mary Lynne Hedley was terminated as Director, effective June 24, 2026.
“each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa and each committee thereof on which such director served.”
Affiliation history
-
Start not stated–2026-06-24